<DOC>
	<DOCNO>NCT02641899</DOCNO>
	<brief_summary>A Phase 1 , Fixed-Sequence , Open-label Study Healthy Subjects Estimate Effects ITCA 650 Gastric Emptying Absorption Pharmacokinetics Each 4 Commonly Studied DDI Probe Compounds .</brief_summary>
	<brief_title>Study Effects ITCA 650 Gastric Emptying Interaction ITCA 650 4 Commonly Studied Drugs</brief_title>
	<detailed_description>Acetaminophen use ass effect ITCA 650 rate gastric emptying . Interactions ITCA 650 medication lisinopril , digoxin , atorvastatin , warfarin also study .</detailed_description>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Digoxin</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Body mass index ( BMI ) 19 32 kg/m2 . Glycosylated hemoglobin A1c ( HbA1c ) &lt; 6.5 % . Normal renal function ( eGFR ≥80 mL/min/1.73 m2 ) . Women child bear potential use additional adequate method contraception study 1 additional menstrual cycle follow endofstudy ( EOS ) visit . Adequate method contraception woman child bear potential ( WOCBP ) include : mechanical product ( ie , intrauterine device [ IUD ] —copper IUD ) ; barrier method ( eg , diaphragm , condom , cervical cap ) spermicide . History type 1 type 2 diabetes . History evidence myocardial infarction , coronary revascularization ( coronary artery bypass graft percutaneous coronary intervention ) , unstable angina , cerebrovascular accident stroke . History uncontrolled hypertension . History evidence acute chronic pancreatitis . History liver disease . History medullary thyroid cancer personal family history multiple endocrine neoplasia type 2 . Poor thyroid , liver , renal function . Weight loss surgery require weight loss medication . History malignancy ( include basal squamous cell carcinoma skin past 5 year ) . ( Subjects disease free 5 year may include . ) History active alcohol substance abuse . Weekly consumption 7 alcoholic beverage females 14 alcoholic beverage male . Excessive xanthine consumption ( 5 cup coffee equivalent per day ) . Treatment medication affect GI motility . Any condition would affect drug transit time absorption ( eg , gastrointestinal bypass surgery , partial total gastrectomy , small bowel resection , chronic diarrhea , vagotomy , chronic gastroesophageal reflux disease , malabsorption , colostomy , Crohn 's disease , ulcerative colitis , celiac sprue ) . History hypersensitivity exenatide . Contraindications warning accord specific label ( ) acetaminophen , atorvastatin , lisinopril , digoxin warfarin therapy . Women pregnant , lactating , plan become pregnant . Concurrent use anticoagulant , include daily low dose aspirin ( 81 mg ) . History positive result screen test hepatitis B and/or hepatitis C and/or human immunodeficiency virus ( HIV ) . Planned inpatient surgery , dental procedure , hospitalization study . Prior current treatment glucagonlike peptide1 ( GLP1 ) receptor agonist ( eg , Bydureon™ , Byetta® , Victoza® , Tanzeum® exogenous native GLP1 ) prior participation ITCA 650 clinical trial . Use intend use drug product inhibits induce cytochrome P450 ( CYP ) 1A2 , CYP2C9 , CYP2C19 , CYP3A4 within 14 day prior first dose warfarin ITCA650 conduct study . History thrombophlebitis , thromboembolic disorder , deep vein thrombophlebitis . Fasting triglyceride upper limit normal Screening . Any gastrointestinal complaint within 7 day prior first dosing . Taking drug natural herbal supplement ( albuterol , antacid , St. John 's Wort ) know interaction atorvastatin , lisinopril , digoxin , warfarin within 7 day prior Day 1 EOS Consumed unwilling refrain grapefruit , cranberry , grapefruit cranberrycontaining product , Seville oranges within 7 day prior Day 1 EOS . Chronic use analgesic , pain medication , nonsteroidal antiinflammatory agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Adult</keyword>
	<keyword>Male</keyword>
	<keyword>Female</keyword>
	<keyword>Volunteers</keyword>
</DOC>